Benzinga | Feb 24, 2021 08:45AM EST

Heron Therapeutics Q4 EPS $(0.68) Down From $(0.65) YoY, Net Product Sales $20.60M Down From $35.08M YoY

Heron Therapeutics (NASDAQ:HRTX) reported quarterly losses of $(0.68) per share. This is a 4.62 percent decrease over losses of $(0.65) per share from the same period last year. The company reported $20.60 million in sales this quarter. This is a 41.28 percent decrease over sales of $35.08 million the same period last year.